LSL Pharma Group Inc
- LAST PRICE0.4200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.3900/ 3
- Ask / Lots0.4200/ 2
- Open / Previous Close0.0000 / 0.4200
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LSL |
|---|---|---|
| 09:54 ET | 5000 | 0.4 |
| 11:49 ET | 36500 | 0.42 |
Yesterday
LSL Pharma Group Reports Its Fourth Quarter and Year-End 2023 Results and Highlights, from 7:00AM ET on Tuesday Apr 30, 2024 by Dow Jones
7:00AM ET on Tuesday Apr 30, 2024 by Dow Jones
Apr 24, 2024
LSL Pharma Group Secures $3.8 Million as the Second and Final Tranche of Its Private Placement of Units, from 7:00AM ET on Wednesday Apr 24, 2024 by Dow Jones
7:00AM ET on Wednesday Apr 24, 2024 by Dow Jones
Apr 23, 2024
Press Release: LSL Pharma Group Announces the Addition of New Members to Its Board of Directors, from 7:03AM ET on Tuesday Apr 23, 2024 by Dow Jones
7:03AM ET on Tuesday Apr 23, 2024 by Dow JonesLSL Pharma Group Announces the Addition of New Members to Its Board of Directors, from 7:00AM ET on Tuesday Apr 23, 2024 by Dow Jones
7:00AM ET on Tuesday Apr 23, 2024 by Dow Jones
Apr 11, 2024
LSL Pharma Group Announces the Upsizing of Its Private Placement From $3.5 Million to $7.5 Million, from 7:00AM ET on Thursday Apr 11, 2024 by Dow Jones
7:00AM ET on Thursday Apr 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
LSL Pharma Group Inc | 45.9M | 0.0x | --- |
BioNxt Solutions Inc | 43.8M | -5.2x | --- |
Medicus Pharma Ltd | 36.7M | -2.2x | --- |
Devonian Health Group Inc | 32.9M | -7.2x | --- |
Pharmather Holdings Ltd | 23.4M | -5.4x | --- |
Nextleaf Solutions Ltd | 24.1M | 26.1x | --- |
Company Information
LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company. The Company is specializing in the development, manufacturing and distribution of natural health products and dietary supplements in solid dosage forms, as well as sterile ophthalmic pharmaceutical products. The Company’s subsidiaries include Steri-Med Pharma Inc., LSL Laboratory Inc. and Groupe Immobilier LSL inc.
Contact Information
- Headquarters
- 540, rue d'Avaugour, Office 1800BOUCHERVILLE, QC, Canada J4B 0G6
- Phone
- 450-681-7744
- Fax
- 450-681-8400
Executives
- Chairman of the Board
- Marcel Tremblay
- President, Chief Executive Officer, Director
- Alain Larochelle
- Chief Financial Officer, Senior Vice President
- Luc Mainville
- Secretary, Director
- Pierre-Hubert Seguin
- Director
- Diane Beaudry
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $45.9M |
|---|---|
Revenue (TTM) | --- |
Shares Outstanding | 108.2M |
LSL Pharma Group Inc does not pay a dividend. | |
Beta | --- |
EPS | --- |
Book Value | $-0.31 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
